University Hospital in Madison joins COVID-19 plasma trial
MADISON — University Hospital in Madison will join a national effort to transfuse antibodies from the plasma of people who recovered from the coronavirus to treat patients still struggling with it.
The technique is a century-old treatment used to fight off flu and measles outbreaks in the days before vaccines, and tried more recently against SARS and Ebola.
With no approved treatment for COVID-19 and more than 11,000 deaths in the U.S., the unproven approach offers some hope against COVID-19.
As of Tuesday night, Wisconsin reported more than 2,500 coronavirus infections and 92 related deaths — 49 of them in Milwaukee County.
“We know that antibody has neutralized the virus in one person,” said Dr. William Hartman, a UW Health anesthesiologist heading up the effort at UW Hospital, which is part of a national study. “We assume that the antibody will neutralize the virus in another person. It’s an extra boost to help fight off the infection.”
UW Hospital has joined the National COVID-19 Convalescent Plasma Project, started about a month ago by Johns Hopkins University, Mayo Clinic and other institutions.
The Food and Drug Administration recently approved a clinical trial at Johns Hopkins, through which UW Hospital’s treatment program will operate, Hartman tells the State Journal.